Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18834-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18834-1-AP, RRID:AB_10603354
- Product name
- ARHGAP24 antibody
- Antibody type
- Polyclonal
- Description
- ARHGAP24 antibody (Cat. #18834-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat, Canine and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse, Rat, Canine
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.
ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42.
Cyclic Mechanical Loading Is Essential for Rac1-Mediated Elongation and Remodeling of the Embryonic Mitral Valve.
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.
Jin X, Zhang B, Zhang H, Yu H
Oncogene 2021 Nov 16;
Oncogene 2021 Nov 16;
ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42.
Wang L, Yang X, Wan L, Wang S, Pan J, Liu Y
Clinical and experimental pharmacology & physiology 2020 Sep;47(9):1591-1599
Clinical and experimental pharmacology & physiology 2020 Sep;47(9):1591-1599
Cyclic Mechanical Loading Is Essential for Rac1-Mediated Elongation and Remodeling of the Embryonic Mitral Valve.
Gould RA, Yalcin HC, MacKay JL, Sauls K, Norris R, Kumar S, Butcher JT
Current biology : CB 2016 Jan 11;26(1):27-37
Current biology : CB 2016 Jan 11;26(1):27-37
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.
Roberts DL, O'Dwyer ST, Stern PL, Renehan AG
Oncotarget 2015 May 10;6(13):10786-800
Oncotarget 2015 May 10;6(13):10786-800
No comments: Submit comment
No validations: Submit validation data